Part,  Chapter, Paragraph

 1   II,     5.  1.  1|          human papilloma virus or HPV (Stewart and Kleihues, 2003).
 2   II,     5.  1.  1|          Kleihues, 2003). Genital HPV is usually spread by sexual
 3   II,     5.  1.  1|      Abnormal cells, derived from HPV infection, take many years
 4   II,     5.  3.Acr|        GDP~Gross Domestic Product~HPV~Human Papilloma Virus~HTA~
 5   II,     5.  3.  4|          human papilloma virus or HPV (Stewart and Kleihues, 2003).
 6   II,     5.  3.  4|          Kleihues, 2003). Genital HPV is usually spread by sexual
 7   II,     5.  3.  4|      Abnormal cells, derived from HPV infection, take many years
 8   II,     5.  3.  5|          is mainly related to the HPV (Human Papilloma Virus)
 9   II,     5.  3.  5|        cervical lesions caused by HPV infection before becoming
10   II,     5.  3.  5|        two countries have similar HPV infection exposure and the
11   II,     5.  3.  5|      could be caused by different HPV exposure and by the different
12   II,     6.Acr    |     Haemophilus Influenzae type B~HPV~Human Papilloma Virus~IDU~
13   II,     6.  3.  3|       with human papilloma virus (HPV) has received renewed interest
14   II,     6.  3.  3|          to define the profile of HPV strains most prevalent in
15   II,     6.  3.  5|            human papilloma virus (HPV), and rotavirus). This raises
16   II,     9        |        and human papilloma virus (HPV). Risk factors for STIs
17   II,     9.  2.  4|        and human papilloma virus (HPV). Risk factors for STIs
18   II,     9.  3.  1|        the human papilloma virus (HPV) are often hidden and can
19   II,     9.  3.  1|      occur years after infection. HPV produces genital warts which
20   II,     9.  3.  1|          cancer shows evidence of HPV infection (Madeleine et
21   II,     9.  3.  1|      genital warts. A vaccine for HPV has become recently available
22   II,     9.  3.  1| immunodeficiency virus infections~HPV~Human papilloma virus~IDF
23   IV,    11.Acr    |         and Healthcare Federation~HPV~Human Papilloma Virus~NICE~
24   IV,    11.  4    |    against Human Papilloma Virus (HPV) to reduce the risk of cervical
25   IV,    12.  2    |        Papilloma Virus infection (HPV), which is a risk factor
26   IV,    12. 10    |   diseases (i.e. Hepatitis B & C, HPV, Syphilis, and Gonorrhea).